English Deutsch Français Italiano Español Português 繁體中文 Bahasa Indonesia Tiếng Việt ภาษาไทย
All categories

4 answers

the difference is adult stem cells have been used to find many cures. the are taken from adult consenting. i think over 72 cures have been found. But not ONE cure or potential cure has ever came from embryonic stem cells. which come from fertilizing and egg and creating life then killing it. the only reason there is such a push for the embryonic is because if any cure is found from them, they can patent it. they cannot if found form adult stem cells. it all about money.

2006-10-24 13:27:25 · answer #1 · answered by mxlj 5 · 0 0

Human embryonic and adult stem cells each have advantages and disadvantages regarding potential use for cell-based regenerative therapies. Of course, adult and embryonic stem cells differ in the number and type of differentiated cells types they can become. Embryonic stem cells can become all cell types of the body because they are pluripotent. Adult stem cells are generally limited to differentiating into different cell types of their tissue of origin. However, some evidence suggests that adult stem cell plasticity may exist, increasing the number of cell types a given adult stem cell can become.

Large numbers of embryonic stem cells can be relatively easily grown in culture, while adult stem cells are rare in mature tissues and methods for expanding their numbers in cell culture have not yet been worked out. This is an important distinction, as large numbers of cells are needed for stem cell replacement therapies.

A potential advantage of using stem cells from an adult is that the patient's own cells could be expanded in culture and then reintroduced into the patient. The use of the patient's own adult stem cells would mean that the cells would not be rejected by the immune system. This represents a significant advantage as immune rejection is a difficult problem that can only be circumvented with immunosuppressive drugs.

Embryonic stem cells from a donor introduced into a patient could cause transplant rejection. However, whether the recipient would reject donor embryonic stem cells has not been determined in human experiments.

More info can be found here:
http://www.stemcellsstocks.com/

2006-10-26 22:53:03 · answer #2 · answered by stocker 3 · 0 0

Embryonic stem cells (ESCs) are stem cells derived from the inner cell mass of a blastocyst, which is an early stage embryo - approximately 4 to 5 days old in humans - consisting of 50-150 cells. Embryonic stem cells are pluripotent, meaning they are able to differentiate into all derivatives of the three primary germ layers: ectoderm, endoderm and mesoderm. In other words, they can develop into each of the more than 200 cell types of the adult body when given sufficient and necessary stimulation for a specific cell type. When given no stimuli for differentiation, ESCs will continue to divide in vitro and each daughter cell will remain pluripotent. The pluripotency of ESCs distinguishes them from adult stem cells or progenitor cells, the latter two only having the capacity to form a more limited number of different cell types.

Because of their unique combined abilities of unlimited expansion and pluripotency, embryonic stem cells are a potential source for regenerative medicine and tissue replacement after injury or disease. To date, no approved medical treatments have been derived from embryonic stem cell research. This is not unusual for a new medical research field; in this case, the first human embryonic stem cell line was only reported in 1998.

2006-10-24 15:13:48 · answer #3 · answered by skip s 2 · 0 1

the level of development

2006-10-24 10:51:04 · answer #4 · answered by Anonymous · 0 0

fedest.com, questions and answers